BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) announced the election of George B. Abercrombie to the Company's board of directors, effective October 10, 2011. The Company also announced today that Stephen R. Biggar, M.D., Ph.D., has stepped down from the board, effective October 10, 2011.
BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule pharmaceuticals that block key enzymes involved in infectious diseases, inflammatory diseases and cancer.
Read full article and disclaimer at : http://doubleinstocks.com/?p=19158
(BCRX, CHOP, WRES, CLNO) Stock Report from DoubleInStocks.com
October 19th, 2011 at 01:33 pm